{
  "main_header": {
    "sid": 1137959,
    "name": "QIAGEN NV",
    "stock_name": "QIAGEN NV",
    "full_name": "QIAGEN NV",
    "name_url": "stocks-analysis/qiagen-nv",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "47.08",
    "chg": 0.26,
    "chgp": "0.56%",
    "dir": 1,
    "prev_price": "46.82",
    "mcapval": "10,428.70",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "NL0015001WM6",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "788.77 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/qiagen-nv-1137959-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is QIAGEN NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-qiagen-nv-technically-bullish-or-bearish-3599129",
        "imagepath": "",
        "date": "2025-10-07 12:19:19",
        "description": "As of 3 October 2025, the technical trend for QIAGEN NV has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST are mildly bearish, contrasting with the monthly indicators which are bullish. The Bollinger Bands also reflect a mildly bearish trend on the weekly timeframe but bullish on the monthly. \n\nIn terms of performance, QIAGEN has underperformed the S&P 500 over the 1-month, 1-year, 3-year, and 5-year periods, with returns of -1.24%, 4.79%, 6.73%, and -13.45% respectively, compared to the S&P 500's returns of 4.15%, 17.82%, 82.57%, and 100.56%. Overall, the current technical stance is mildly bullish, but the mixed signals from various indicators suggest caution...."
      },
      {
        "title": "Is QIAGEN NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-qiagen-nv-technically-bullish-or-bearish-3593853",
        "imagepath": "",
        "date": "2025-10-06 12:09:11",
        "description": "As of 3 October 2025, the technical trend for QIAGEN NV has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and Bollinger Bands show mildly bearish signals. However, the monthly MACD and Bollinger Bands are bullish, suggesting some strength in the longer term. Overall, the mixed signals indicate a mildly bullish sentiment. In terms of performance, QIAGEN has underperformed the S&P 500 over the 1-month, 1-year, 3-year, and 5-year periods, but it has outperformed in the past week...."
      },
      {
        "title": "Is QIAGEN NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-qiagen-nv-technically-bullish-or-bearish-3591926",
        "imagepath": "",
        "date": "2025-10-05 11:54:11",
        "description": "As of 3 October 2025, the technical trend for QIAGEN NV has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the monthly MACD and Bollinger Bands also support a bullish outlook. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The stock has shown a strong 1-week return of 6.61% compared to the S&P 500's 1.09%, but the longer-term returns are lagging, with a 5-year return of -10.55% versus the S&P 500's 100.56%. Overall, the current technical stance is mildly bullish, driven by daily moving averages and monthly indicators, despite mixed signals from weekly metrics...."
      },
      {
        "title": "Is QIAGEN NV technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-qiagen-nv-technically-bullish-or-bearish-3546789",
        "imagepath": "",
        "date": "2025-09-20 19:40:34",
        "description": "As of 27 August 2025, the technical trend for QIAGEN NV has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a mildly bearish stance, while the monthly indicators show a mildly bullish trend. The daily moving averages are mildly bullish, suggesting some short-term strength. Overall, the technical stance is mildly bullish, but the mixed signals from various time frames indicate caution.\n\nIn terms of performance, QIAGEN has underperformed the S&P 500 across multiple periods, with a year-to-date return of -0.14% compared to the S&P 500's 12.22%, and a 5-year return of -14.74% versus the S&P 500's 96.61%...."
      },
      {
        "title": "Is QIAGEN NV overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-qiagen-nv-overvalued-or-undervalued-3543286",
        "imagepath": "",
        "date": "2025-09-20 18:15:33",
        "description": "As of 9 September 2025, the valuation grade for QIAGEN NV has moved from expensive to fair, indicating a more favorable assessment of its market position. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 20, an EV to EBIT of 19.95, and a PEG ratio of 0.59, which suggests that the stock is reasonably priced relative to its earnings growth potential.\n\nIn comparison to peers, QIAGEN NV's P/E ratio of 24.20 is higher than Hologic, Inc.'s P/E of 21.83, but lower than The Cooper Companies, Inc.'s P/E of 34.28, indicating a competitive standing within the industry. Despite this fair valuation, QIAGEN NV has underperformed against the S&P 500 over multiple periods, with a 5-year return of -14.74% compared to the S&P 500's 96.61%, highlighting potential concerns regarding its growth trajectory...."
      }
    ],
    "total": 10,
    "sid": "1137959",
    "stock_news_url": "https://www.marketsmojo.com/news/qiagen-nv-1137959"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is QIAGEN NV technically bullish or bearish?

2025-10-07 12:19:19

As of 3 October 2025, the technical trend for QIAGEN NV has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and KST are mildly bearish, contrasting with the monthly indicators which are bullish. The Bollinger Bands also reflect a mildly bearish trend on the weekly timeframe but bullish on the monthly. In terms of performance, QIAGEN has underperformed the S&P 500 over the 1-month, 1-year, 3-year, and 5-year periods, with returns of -1.24%, 4.79%, 6.73%, and -13.45% respectively, compared to the S&P 500's returns of 4.15%, 17.82%, 82.57%, and 100.56%. Overall, the current technical stance is mildly bullish, but the mixed signals from various indicators suggest caution....

Read More

Is QIAGEN NV technically bullish or bearish?

2025-10-06 12:09:11

As of 3 October 2025, the technical trend for QIAGEN NV has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly MACD and Bollinger Bands show mildly bearish signals. However, the monthly MACD and Bollinger Bands are bullish, suggesting some strength in the longer term. Overall, the mixed signals indicate a mildly bullish sentiment. In terms of performance, QIAGEN has underperformed the S&P 500 over the 1-month, 1-year, 3-year, and 5-year periods, but it has outperformed in the past week....

Read More

Is QIAGEN NV technically bullish or bearish?

2025-10-05 11:54:11

As of 3 October 2025, the technical trend for QIAGEN NV has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the monthly MACD and Bollinger Bands also support a bullish outlook. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The stock has shown a strong 1-week return of 6.61% compared to the S&P 500's 1.09%, but the longer-term returns are lagging, with a 5-year return of -10.55% versus the S&P 500's 100.56%. Overall, the current technical stance is mildly bullish, driven by daily moving averages and monthly indicators, despite mixed signals from weekly metrics....

Read More

Is QIAGEN NV technically bullish or bearish?

2025-09-20 19:40:34

As of 27 August 2025, the technical trend for QIAGEN NV has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a mildly bearish stance, while the monthly indicators show a mildly bullish trend. The daily moving averages are mildly bullish, suggesting some short-term strength. Overall, the technical stance is mildly bullish, but the mixed signals from various time frames indicate caution. In terms of performance, QIAGEN has underperformed the S&P 500 across multiple periods, with a year-to-date return of -0.14% compared to the S&P 500's 12.22%, and a 5-year return of -14.74% versus the S&P 500's 96.61%....

Read More

Is QIAGEN NV overvalued or undervalued?

2025-09-20 18:15:33

As of 9 September 2025, the valuation grade for QIAGEN NV has moved from expensive to fair, indicating a more favorable assessment of its market position. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 20, an EV to EBIT of 19.95, and a PEG ratio of 0.59, which suggests that the stock is reasonably priced relative to its earnings growth potential. In comparison to peers, QIAGEN NV's P/E ratio of 24.20 is higher than Hologic, Inc.'s P/E of 21.83, but lower than The Cooper Companies, Inc.'s P/E of 34.28, indicating a competitive standing within the industry. Despite this fair valuation, QIAGEN NV has underperformed against the S&P 500 over multiple periods, with a 5-year return of -14.74% compared to the S&P 500's 96.61%, highlighting potential concerns regarding its growth trajectory....

Read More

View All News